Zobrazeno 1 - 10
of 67
pro vyhledávání: '"S Greenfeld"'
Autor:
Jeremy S. Greenfeld
Publikováno v:
Phi Delta Kappan. 103:37-42
Preparing students for postsecondary life is among the most important roles that a high school plays. And yet, how schools approach this work, what schools should be preparing students for, and who should be responsible for this work have long been c
Autor:
Doron Schwartz, Saleh Daher, Esther Orlanski-Meyer, N Ledderman, Revital Kariv, Dan Turner, Yiska Loewenberg Weisband, Daniel Nevo, Iris Dotan, Henit Yanai, Eran Israeli, Ohad Atia, E Matz, S Greenfeld, Hagit Gabay, Yehuda Chowers, Rona Lujan
Publikováno v:
Journal of Crohn's and Colitis. 16:778-785
Background The effectiveness of biologics for improving long-term outcomes in patients with Crohn’s disease [CD] is still controversial. In this nationwide study, we aimed to evaluate trends of long-term outcomes in all CD patients in Israel during
Autor:
Yuri Gorelik, Sigal Pressman, S Greenfeld, Nathan Lederman, Chagit Friss, Naama Geva-Zatorsky, Yechezkel Kashi, Yehuda Chowers, Alexandera Blatt, Revital Kariv, Shay Freilich, G Focht, Shiran Gerassy-Vainberg, Yiska Loewenberg Weisband, Shai S. Shen-Orr, Iris Dotan
Publikováno v:
Gut
ObjectiveAnti-drug antibodies (ADA) to anti-tumour necrosis factor (anti-TNF) therapy drive treatment loss of response. An association between intestinal microbial composition and response to anti-TNF therapy was noted. We therefore aimed to assess t
Autor:
E Boaz, O Ledder, A Dagan, R Lujan, B Koslowsky, C Friss, S Greenfeld, R Kariv, Y Loewenberg Weisband, N Lederman, E Matz, I Dotan, S Yellinek, D Turner
Publikováno v:
Journal of Crohn's and Colitis. 17:i135-i136
Background In this nationwide study, we aimed to explore health services utilization, medical management, and disease outcomes of inflammatory bowel diseases (IBD) between Jews and Arabs, the two major ethnic groups in Israel. Methods We utilized a c
Autor:
R Lujan, O Atia, G Focht, S Greenfeld, R Kariv, Y Loewenberg Weisband, N Lederman, E Matz, I Dotan, D Turner
Publikováno v:
Journal of Crohn's and Colitis. 17:i975-i976
Background There is uncertainty about the ability to predict disease course in UC, often since prediction studies are small and include selected population. We aimed to use a large nationwide cohort to explore predictors of disease course in UC. Meth
Autor:
R Lev Zion, A S Dolev, S Greenfeld, R Kariv, N Ledderman, E Matz, I Dotan, U Kopylov, D Turner, B Lerner
Publikováno v:
Journal of Crohn's and Colitis. 17:i417-i418
Background Recent studies such as the GEM project have identified microbial, serological and metabolomic markers that may help predict inflammatory bowel disease (IBD) well in advance of diagnosis, with the ultimate goal of pre-disease prevention. In
Autor:
G Focht, R Lujan, O Atia, S Greenfeld, R Kariv, Y Loewenberg Weisband, N Lederman, E Matz, I Dotan, D Turner
Publikováno v:
Journal of Crohn's and Colitis. 17:i17-i18
Background Studies have reported conflicting findings regarding the effect of timing of biologics initiation on disease course, often affected by selection and referral biases. In this nationwide cohort study we aimed to explore whether early initiat
Autor:
L Plotkin, R Lujan, G Focht, S Greenfeld, Y Loewenberg Weisband, N Lederman, E Matz, I Dotan, D Turner
Publikováno v:
Journal of Crohn's and Colitis. 17:i46-i47
Background Studies have shown that exclusive enteral nutrition (EEN) treatment is as effective to corticosteroids (CS) for induction of remission in pediatric Crohn's disease (CD) with fewer side effects, but long-term outcome data are scarce. In thi
Autor:
O Atia, I Goren, T Sharar Fischler, Y Loewenberg Weisband, S Greenfeld, R Kariv, N Ledderman, E Matz, R Magen Rimon, I Dotan, D Turner, H Yanai
Publikováno v:
Journal of Crohn's and Colitis. 17:i596-i596
Background 5-aminosalicylates (5-ASA) are widely used in Crohn's disease (CD) despite guidelines advising otherwise. In this nationwide study, we aimed to assess the outcomes of first-line 5-ASA-maintenance therapy (5-ASA-MT) compared with no-mainten
Publikováno v:
Journal of Crohn's and Colitis. 16:i584-i585
Background Identifying prognostic factors of therapeutic failure, may facilitate balancing the risks and benefits of biologic treatment. In this population-based study, we aimed to explore predictors of therapeutic failure of biologics in Ulcerative